Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomyTakuya Koie, Yuki Tobisawa, Koji Mitsuzuka et al.|International Journal of Clinical Oncology|2014Cited by 40
Clinical implications of serum <i>N‐</i>glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumorsTakuma Narita, Chikara Οhyama, Shintaro Narita et al.|Cancer Medicine|2017Cited by 26
Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysisTakuya Koie, Yuki Tobisawa, Koji Mitsuzuka et al.|International Journal of Clinical Oncology|2015Cited by 23
Machine learning diagnosis by immunoglobulin<i>N</i>‐glycan signatures for precision diagnosis of urological diseasesHiromichi Iwamura, Tohru Yoneyama, Kei Mizuno et al.|Cancer Science|2022Cited by 16
1931 SINGLE POSITIVE BIOPSY AND PSA LEVEL <10NG/ML WITH PROSTATE CANCER PATIENTS CAN NOT PREDICT UNILATERAL LESION IN RADICAL PROSTATECTOMY SPECIMENS IN CONTEMPORARY JAPANESE POPULATIONTakuya Koie, Chikara Οhyama, Koji Mitsuzuka et al.|The Journal of Urology|2013Cited by 0